✦ LIBER ✦

CMV-IVIG for Prevention of Epstein Barr Virus Disease and Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant Recipients

✍ Scribed by M. Green; M. G. Michaels; B. Z. Katz; M. Burroughs; D. Gerber; B. L. Shneider; K. Newell; D. Rowe; J. Reyes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Epstein-Barr Virus and Posttransplant Ly

✍ U. Allen; J. Preiksaitis; the AST Infectious Diseases Community of Practice 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Incidence, management, and outcome of po

✍ E.P Molmenti; D Nagata; J Roden; R Squires; H Molmenti; D Casey; C Fasola; M.Jam 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Cellular Immunity to Epstein-Barr Virus

✍ Barbara Savoldo; Cliona M. Rooney; Ruben E. Quiros-Tejeira; Yvette Caldwell; Han 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Graft rejection in pediatric liver trans

✍ Chana Weiner; Lauren Weintraub; Birte Wistinghausen; Juli Tomaino; Ronen Arnon; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB

Natural history of epstein-barr viral lo

✍ T.V Cacciarelli; J Reyes; G.V Mazariegos; L Sigurdsson; D.T Rowe; J.J Fung; M Gr 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Factors associated with the development

✍ Rafael Mañez; Mary K. Breinig; Peter Linden; Shimon Kusne; Julian Torre-Cisneros 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 192 KB